Everything You Need to Know about Viva Biotech 2022 Annual Results

Publication time:

March 30, 2023

Next article :

ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor

Previous article :

VivaVision Completed 300 Million RMB Series D Financing